1.Associations of Oxalate Consumption and Some Individual Habits with the Risk of Kidney Stones.
Nahid ZAINODINI ; Periklis DOUSDAMPANIS ; Zahra AHMADI ; Maryam MOHAMADI ; Alireza NAZARI
Chinese Medical Sciences Journal 2023;38(3):250-256
Kidney stone is a highly recurrent disease in the urinary tract system. Most kidney stones are calcium stones, usually consisting of either calcium oxalate or calcium phosphate. Supersaturation of soluble calcium, oxalate, phosphate, and citrate in the urine is the basis for calcium stone formation. Genetics, diet, low physical activity, and individual habits contribute to the formation of kidney stones. In this review, the associations of the risk of kidney stones with oxalate consumption and some individual habits, such as smoking, alcohol drinking, and opium consumption, are summarized.
Humans
;
Calcium/urine*
;
Oxalates
;
Kidney Calculi/urine*
;
Calcium Oxalate/urine*
;
Habits
3.Clinical Results of Piezoelectric Shock Wave Lithotripsy for Treatment of Patients with Urolithiasis.
Sung Goo CHANG ; Soo Eung CHAE
Korean Journal of Urology 1989;30(4):560-568
Extracorporeal shock wave lithotripsy(ESWL) is becoming treatment of choice for most upper tract calculi, and especially EDAP made piezoelectric E. S. W. L. can treat kidney, upper ureter and lower ureter stones. We present the results of 245 consecutive treatments performed between May, 1987 and February, 1988 with piezoeletric shock wave lithotriptor. 1. The oldest patient was age of 78 and the youngest patient was age of 15 and there was no contraindication due to other systemic disease. 2. No anesthesia were required and only narcotics were given for pain that induced from shock wave, but one, 18 years old female with renal stone was treated with ketamine. 3. Response rate revealed that complete response was 174 cases (71%), partial response was 63 cases (25.7%) and non-response was 8 cases (3.3%). 4. In complete response cases, average requirement of shock wave storages were noted that renal stone was 323, upper ureter stone was 562 and lower ureter stone was 377 and then the shock wave storage was increase depend upon the location of the stone, such as kidney, lower ureter stone and upper ureter stone in priority. 5. Staghorn calculi, multiple renal stones, caliceal diverticular stones, renal stones with migration into the ureter while treatment, impact ureter stones, ureter stones with larger than 2.5 cm and obesity were poor response factors. 6. We adopted push up (9 cases), double J stent (6 cases), stone basket (6 cases), URS.(2 cases) and nephrostomy (1 cases) as auxiliary procedure. 7. Chemical composition of treated stones were that calcium oxalate and phosphate mixed stone8 were 50.6%, calcium oxalates 33.5%, struvites 10.5%, uric acid 3.9% and calcium phosphate 1.3%. 8. We experienced 11 cases (4.4%) of complications: 5 cases of stone street, 3 cases of post ESWL flank pain, 1 case of high fever, 1 case of sepsis and 1 case of perirencal hematoma. 9. As a result, we suggest that we should consider stone size, location, situation of patient and history of stone surgery for good effectiveness from treatment with E.S.W.L.
Adolescent
;
Anesthesia
;
Calcium
;
Calcium Oxalate
;
Calculi
;
Female
;
Fever
;
Flank Pain
;
Hematoma
;
Humans
;
Ketamine
;
Kidney
;
Lithotripsy*
;
Narcotics
;
Obesity
;
Oxalates
;
Sepsis
;
Shock*
;
Stents
;
Ureter
;
Uric Acid
;
Urinary Calculi
;
Urolithiasis*
4.Development of Yvrk Gene-Recombinant E. coli Degrading Oxalate.
Byong Chang JEONG ; Yong Hyun PARK ; Hyeon Hoe KIM
Korean Journal of Urology 2009;50(10):1022-1026
PURPOSE: Recently, the whole DNA sequence of Bacillus subtilis (B. subtilis) was identified, revealing the existence of the YvrK gene encoding a 43 kD oxalate decarboxylase (OXDC), which degrades oxalate by a simple pathway. The objective of this study was to develop recombinant Escherichia coli (E. coli) expressing the Yvrk gene from B. subtilis. MATERIALS AND METHODS: After the extraction of total DNA from B. subtilis, the YvrK gene was cloned by polymerase chain reaction. The cloned DNA encoding OXDC was inserted into the pBAD/gIII-A vector, downstream of the L-arabinose promotor. The plasmid vector was transformed into TOP 10 E. coli, and the transformants were selected with ampicillin. The recombinant E. coli, named pBy, was then analyzed by DNA sequencing and Western blot. To evaluate the oxalate-degrading function of pBy, pBy was cultured in LB broth containing oxalate, and then the amount of oxalate in the medium was assessed. The oxalate-degrading activity of homogenates of pBy was evaluated. RESULTS: DNA sequencing showed the successful transformation of the YvrK gene into TOP 10 E. coli. Western blot analyses showed that pBy expressed OXDC. pBy removed oxalate during the overnight culture in oxalate-containing LB broth, and the homogenate of pBy degraded 90% of oxalate under acidic conditions. CONCLUSIONS: A recombinant E. coli expressing the YvrK gene was successfully produced. The bacteria showed potent oxalate-degrading activity. The results of this study will provide a solution to the treatment of calcium oxalate stones and hyperoxaluria, for which there are few medical treatment modalities.
Ampicillin
;
Arabinose
;
Bacillus subtilis
;
Bacteria
;
Base Sequence
;
Blotting, Western
;
Calcium Oxalate
;
Carboxy-Lyases
;
Clone Cells
;
DNA
;
Escherichia coli
;
Hyperoxaluria
;
Oxalates
;
Plasmids
;
Polymerase Chain Reaction
;
Sequence Analysis, DNA
5.Determination of urine oxalate level in rats with renal calcium oxalate calculus by high-performance liquid chromatography.
Qiu-shi CAO ; Yuan-ming BA ; Jun-hua LUO ; Qi DAI
Acta Academiae Medicinae Sinicae 2015;37(1):82-87
OBJECTIVETo establish a method of high-performance liquid chromatography (HPLC) for determining the urine oxalate levle in rats with renal calcium oxalate calculus.
METHODSTotally 24 SPF Wistar healthy male rats were randomly divided into control group(n=12)and ethylene glycol (EG) group (n=12). Rats in EG group were administered intragastrically with 2% ammonium chloride (AC)2 ml/rat per day+1% ethylene glycol (EG), along with free access to drinking water.The control group was fed with deionized water, along with the intragastric administration of normal saline (1 ml per day). Twenty-eight days after modelling, the 24-hour urine samples were collected, and the urine oxalic acid levels were determined using HPLC and the results were compared with those of catalytic spectrophotometry using oxidation of methyl. During the HPLC, the samples were separated on Aglient 5TC-C18 (250×4.6 mm,5 Μm), eluted with mixture of methanol (0.1 mol/L) and ammonium acetate (15:85) at 1.2 ml/min, and detected at 314 nm, with the column temperature being 20 ℃.
RESULTSThe standard curves of high and low concentrations of oxalic acid were y=5909.1x+378730, R² =0.9984 and y=7810.5x-16635, R² =0.9967,respectively. The lowest detectable concentration in this method was 5 Μg/ml. The linear high concentration range of oxalate stood at 62.50-2000.00 Μg/ml, and the linear low concentration range of oxalate stood at 6.25-100.00 Μg/ml. Its average recovery was 95.1%, and its within-day and day-to-day precisions were 3.4%-10.8% and 3.8%-9.4%. Both HPLC and catalytic spectrophotometry showed significantly higher urinary oxalic acid concentration and 24 h urine oxalate level in EG group compared with the control group [urinary oxalic acid concentration: (736.35 ± 254.52) Μg/ml vs.(51.56 ± 36.34) Μg/ml,(687.35 ± 234.53) Μg/ml vs.(50.24 ± 42.34) Μg/ml;24 h urine oxalate level: (11.23 ± 4.12)mg vs.(0.87 ± 0.45)mg,(9.89 ± 3.55)mg vs. (0.77 ± 0.65)mg; all P<0.01]. No statistically significant difference was observed in the results of urinary oxalate concentration and 24 h urine oxalate level between HPLC and potassium chromate oxidation of methyl red spectrophotometry (all P>0.05).
CONCLUSIONHPLC is a simple, rapid, and precise method in detecting urine oxalate level in rats with renal calcium oxalate calculus, with high recovery rate.
Acetates ; Animals ; Azo Compounds ; Calcium Oxalate ; Calculi ; Chromates ; Chromatography, High Pressure Liquid ; Kidney ; Male ; Oxalates ; Potassium Compounds ; Rats ; Rats, Wistar ; Spectrophotometry ; Water
6.Peanut-induced acute oxalate nephropathy with acute kidney injury.
Hyeoncheol PARK ; Minseob EOM ; Jae Won YANG ; Byoung Geun HAN ; Seung Ok CHOI ; Jae Seok KIM
Kidney Research and Clinical Practice 2014;33(2):109-111
Oxalate nephropathy is commonly caused by ethylene glycol, vitamin C, and foods like star fruit that contain a lot of oxalate. Peanuts also have high oxalate contents. However, case reports of peanut-induced oxalate nephropathy are not common. Here, we describe a case of peanut-induced acute oxalate nephropathy with acute kidney injury and intend to demonstrate the conditions under which peanut-induced oxalate nephropathy is likely to occur.
Acute Kidney Injury*
;
Arachis
;
Ascorbic Acid
;
Ethylene Glycol
;
Fruit
;
Oxalates
8.Effect of autophagy on oxalate-induced toxicity of human proximal renal tubular epithelial cell.
Danqi LIU ; Jun LEI ; Kai HUANG ; Guangming YIN
Journal of Central South University(Medical Sciences) 2021;46(3):221-226
OBJECTIVES:
To investigate the role of autophagy in oxalate-induced toxicity of human proximal renal tubular epithelial cell (HK-2).
METHODS:
HK-2 cells were exposed to oxalate (1 mmol/L) for 2 h and 3-methyladenine (3-MA) was used to inhibit autophagy. Then Western blotting was used to measure the expression of autophagy-related protein LC3II. Cell viability and cell apoptosis were measured by MTT assay and flow cytometry assay, respectively.
RESULTS:
Cytoplasmic vacuolization was observed in HK-2 cells after treating with oxalate for 2 h. However, 3-MA showed no effects on the formation of cytoplasmic vacuolization regardless of the dose at 1 or 5 mmol/L. The expression of LC3II protein was significantly increased in the HK-2 cells in the presence of oxalate (0.62±0.03 vs 0.35±0.02,
CONCLUSIONS
Autophagy of HK-2 cells is enhanced by oxalate at the concentration of 1 mmol/L. Inhibition of 3-MA-induced autophagy protects HK-2 cells from the oxalate-induced cytotoxicity.
Apoptosis
;
Autophagy
;
Cell Line
;
Epithelial Cells
;
Humans
;
Oxalates/toxicity*
9.Difference Between Nursing Demand and Perceived Nursing Performance in Hemodialysis Patients.
Journal of Korean Academy of Fundamental Nursing 2011;18(3):310-316
PURPOSE: In the present study, the difference in patients' nursing demands and nursing performance as perceived by the patients was examined. METHODS: The participants were 272 patients on maintenance hemodialysis at five university hospitals. Nursing need and nursing performance were measured using the tool developed by Lee for this study. RESULTS: The mean score for nursing demand was 3.35 points out of 4. The scores were higher for participants with middle school graduation or less, those not professing religion, and those whose medical insurance was of the medicaid type. The mean score for perceived nursing performance was 3.22 points out of 4. Nursing performance as perceived by hemodialysis patients was lower than nursing demand for 22 of 28 items. The item with the largest difference between nursing performance and nursing demand was 'Give a pain-free injection', followed by 'Explain about insurance benefits and supports' and 'Maintain quiet environment in the hemodialysis unit enabling rest during hemodialysis'. CONCLUSION: The results show that nursing performance as perceived by hemodialysis patients was lower than nursing demand. This result indicates a need to develop appropriate strategies to enhance nursing performance, especially for items that showed low nursing performance.
Hospitals, University
;
Humans
;
Insurance
;
Insurance Benefits
;
Medicaid
;
Oxalates
;
Renal Dialysis
10.Frovatriptan is Effective and Well Tolerated in Korean Migraineurs: A Double-Blind, Randomized, Placebo-Controlled Trial.
Heui Soo MOON ; Min Kyung CHU ; Jeong Wook PARK ; Kyungmi OH ; Jae Myun CHUNG ; Yong Jin CHO ; Eung Gyu KIM ; Jin Kuk DO ; Hyong Gi JUNG ; Sun Uck KWON
Journal of Clinical Neurology 2010;6(1):27-32
BACKGROUND AND PURPOSE: Frovatriptan is a selective 5-HT1B/1D agonist with a long duration of action and a low incidence of side effects. Although several placebo-controlled trials have documented the clinical efficacy and safety of frovatriptan in adults with migraine, this drug has not previously been studied in Asian including Korean patients. METHODS: In this double-blind multicenter trial, 229 patients with migraine were randomized to receive frovatriptan 2.5 mg or placebo upon the occurrence of a moderate-to-severe migraine. The primary outcome was the 2-hour headache response rate. RESULTS: Frovatriptan significantly increased the 2-hour headache response rate compared with placebo (52.9% vs. 34.0%, p=0.004). The headache response rates at 4, 6, and 12 hours were significantly higher in the frovatriptan group than in the placebo group, as was the pain-free rate at 2 hours (19.0% vs. 5.7%, p=0.004), 4 hours (40.7% vs. 23.0%, p=0.006), and 6 hours (56.1% vs. 34.0%, p=0.002). The median time to a headache response was significantly shorter in the frovatriptan group than in the placebo group (2.00 hours vs. 3.50 hours, p<0.001). The use of rescue medications was more common in the placebo group (p=0.005). Chest tightness associated with triptan was infrequent (2.5%), mild, and transient. CONCLUSIONS: These results demonstrate that 2.5-mg frovatriptan is effective and well tolerated in Korean migraineurs for acute treatment of migraine attacks.
Adult
;
Asian Continental Ancestry Group
;
Carbazoles
;
Headache
;
Humans
;
Incidence
;
Migraine Disorders
;
Oxalates
;
Thorax
;
Tryptamines